Brief: Regent Pacific Group Announces Licence Agreement With Wanbang Pharmaceutical Marketing & Distribution To Launch Fortacin In PRC
03/12/2018 10:23
Dec 3 (Reuters) - Regent Pacific Group Ltd 0575.HK :
* ANNOUNCES LICENCE AGREEMENT WITH WANBANG PHARMACEUTICAL
MARKETING AND DISTRIBUTION CO LTD FOR LAUNCH OF FORTACIN IN PRC
* REGENT PACIFIC TO RECEIVE UP TO US$13 MILLION IN UPFRONT
LICENCE
PAYMENTS AND UPON LAUNCH OF FIRST COMMERCIAL SALES
Source text for Eikon: urn:newsml:reuters.com:*:nHKS8sX5rT
Further company coverage: 0575.HK
(Reuters.Briefs@thomsonreuters.com)
Recent news on Regent Pacific
See all newsBrief: Regent Pacific Says SenstendTM Approved By NMPA For Premature Ejaculation In China
Brief: Regent Pacific Says Deep Longevity To Launch U.S. Expansion In Q1 2026
Brief: Regent Pacific Shall Allot And Issue 63.4 Million Shares At Hk$0.485 Per Share
Brief: Regent Pacific Announces Submission Of Senstend New Drug Application To NMPA In China
Brief: Regent Pacific Enters Manufacturing And Supply Agreement For SENSTEND